<DOC>
	<DOCNO>NCT00814268</DOCNO>
	<brief_summary>Primary objective : - Comparison efficacy combination therapy ( clopidogrel plus aspirin ) aspirin alone ( main comparison ) prevent recurrent ischemic lesion . Secondary objective : - Comparison Modified Rankin scale ( mRS ) score ; - Comparison Incidence kinds stroke vascular death ; - Comparison Incidence bleeding episode ( major minor ) symptomatic intracerebral hemorrhage follow-up period .</brief_summary>
	<brief_title>COMbination Clopidogrel Aspirin Prevention Early REcurrence Acute Atherothrombotic Stroke</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<criteria>Ischemic stroke diagnose within 48 hour symptom onset ; Cerebral ischemic lesion observe diffusionweighted magnetic resonance imaging ( DWI MRI ) ; Relevant atherothrombotic lesion magnetic resonance angiography ( MRA ) compute tomography angiography ( CTA ) ; Study drug administration within 48 hour symptom onset ; mRS score 02 stroke . Evidences relevant brain lesion Intracerebral hemorrhage ( ICH ) brain tumor ; Suspicious stroke due smallvessel occlusion ; Stroke due cardioembolism ; Clinical necessity conventional angiography intervention end study ; Past history ICH ; Bleeding diathesis coagulopathy ; Chronic anemia ( Hb &lt; 8.0 ) thrombocytopenia ( PLT &lt; 100K ) ; Chronic liver disease ( AST &gt; 100 ALT &gt; 100 ) ; Any clinically relevant serious disease , include renal failure ( creatinine clearance &lt; 30mL/min ) ; Allergy Aspirin clopidogrel ; Subjected intervention surgical treatment within 3 month ; Thrombolysis perform rtPA UK stroke ; Participation another clinical study within previous 30 day ; Suspicious poor drug compliance requirement protocol ; Females pregnant , breastfeed , childbearing potential use medically acceptable effective contraception . The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>